These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10517524)
1. The effect of the chain length of polynucleotides on their binding with platinum complexes. Stefanov VE; Tulub AA; Kutin AA Int J Biol Macromol; 1999 Nov; 26(2-3):161-6. PubMed ID: 10517524 [TBL] [Abstract][Full Text] [Related]
2. Formation of adenine-N3/guanine-N7 cross-link in the reaction of trans-oriented platinum substrates with dinucleotides. Liu Y; Vinje J; Pacifico C; Natile G; Sletten E J Am Chem Soc; 2002 Oct; 124(43):12854-62. PubMed ID: 12392432 [TBL] [Abstract][Full Text] [Related]
3. Arapen: a secondary complex between platinum ethylenediamine dichloride and cytosine arabinoside. I. Preparations and reactivity towards nucleic acid constituents. Robins AB Chem Biol Interact; 1976 Jun; 13(3-4):205-13. PubMed ID: 1269043 [TBL] [Abstract][Full Text] [Related]
4. Guanine-06 methylation reduces the reactivity of d(GpG) towards platinum complexes. Struik AF; Zuiderwijk CT; van Boom JH; Elding LI; Reedijk J J Inorg Biochem; 1991 Dec; 44(4):249-60. PubMed ID: 1765785 [TBL] [Abstract][Full Text] [Related]
5. Raman spectroscopic evaluation of DNA adducts of a platinum containing anticancer drug. Jangir DK; Mehrotra R Spectrochim Acta A Mol Biomol Spectrosc; 2014 Sep; 130():386-9. PubMed ID: 24810023 [TBL] [Abstract][Full Text] [Related]
6. NMR studies of models having the Pt(d(GpG)) 17-membered macrocyclic ring formed in DNA by platinum anticancer drugs: Pt complexes with bulky chiral diamine ligands. Saad JS; Benedetti M; Natile G; Marzilli LG Inorg Chem; 2011 May; 50(10):4559-71. PubMed ID: 21510625 [TBL] [Abstract][Full Text] [Related]
7. Interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA. Temple MD; McFadyen WD; Holmes RJ; Denny WA; Murray V Biochemistry; 2000 May; 39(18):5593-9. PubMed ID: 10820033 [TBL] [Abstract][Full Text] [Related]
8. Pt-bridges in various single-strand and double-helix DNA sequences. DFT and MP2 study of the cisplatin coordination with guanine, adenine, and cytosine. Pavelka M; Burda JV J Mol Model; 2007 Feb; 13(2):367-79. PubMed ID: 17024406 [TBL] [Abstract][Full Text] [Related]
9. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)]. Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of nuclear factor kappaB proteins-platinated DNA interactions correlates with cytotoxic effectiveness of the platinum complexes. Brabec V; Kasparkova J; Kostrhunova H; Farrell NP Sci Rep; 2016 Aug; 6():28474. PubMed ID: 27574114 [TBL] [Abstract][Full Text] [Related]
11. cis-1,4-diaminocyclohexane-Pt(II) and -(IV) adducts with DNA bases and nucleosides. Ali MS; Khokhar AR J Inorg Biochem; 2003 Sep; 96(4):452-6. PubMed ID: 13678810 [TBL] [Abstract][Full Text] [Related]
12. Unrestrained 5 ns molecular dynamics simulation of a cisplatin-DNA 1,2-GG adduct provides a rationale for the NMR features and reveals increased conformational flexibility at the platinum binding site. Elizondo-Riojas MA; Kozelka J J Mol Biol; 2001 Dec; 314(5):1227-43. PubMed ID: 11743736 [TBL] [Abstract][Full Text] [Related]
13. The interactions of square platinum(II) complexes with guanine and adenine: a quantum-chemical ab initio study of metalated tautomeric forms. Burda JV; Sponer J; Leszczynski J J Biol Inorg Chem; 2000 Apr; 5(2):178-88. PubMed ID: 10819463 [TBL] [Abstract][Full Text] [Related]
14. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O. Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801 [TBL] [Abstract][Full Text] [Related]
15. On the competition of the purine bases, functionalities of peptide side chains, and protecting agents for the coordination sites of dicationic cisplatin derivatives. Deubel DV J Am Chem Soc; 2002 May; 124(20):5834-42. PubMed ID: 12010058 [TBL] [Abstract][Full Text] [Related]
16. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2]. Brabec V; Vrána O; Nováková O; Kleinwächter V; Intini FP; Coluccia M; Natile G Nucleic Acids Res; 1996 Jan; 24(2):336-41. PubMed ID: 8628659 [TBL] [Abstract][Full Text] [Related]
17. GA and AG sequences of DNA react with cisplatin at comparable rates. Monjardet-Bas V; Bombard S; Chottard JC; Kozelka J Chemistry; 2003 Oct; 9(19):4739-45. PubMed ID: 14566881 [TBL] [Abstract][Full Text] [Related]
18. Loss of amine from platinum(II) complexes: implications for cisplatin inactivation, storage, and resistance. Lau JK; Deubel DV Chemistry; 2005 Apr; 11(9):2849-55. PubMed ID: 15744707 [TBL] [Abstract][Full Text] [Related]
19. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex. Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702 [TBL] [Abstract][Full Text] [Related]
20. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure. Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]